Generic name: Dexrazoxane
Zinecard is a medicine to decrease heart problems severity and incidence caused by doxorubicin (chemotherapy agent) in women having metastatic breast cancer treatment.
It refers to cardioprotective agents. Exactly how this medicine works is unknown, but it affects harmful chemicals inside the cells responsible (partially) for heart disorders associated with doxorubicin.